Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06438692
NA

Ablation Strategies for Persistent Atrial Fibrillation Combined With Heart Failure

Sponsor: Qianfoshan Hospital

View on ClinicalTrials.gov

Summary

(1) To evaluate the efficacy and safety of "2C3L" strategy combined with VOM anhydrous ethanol chemical ablation for persistent atrial fibrillation complicated with heart failure; (2) To evaluate the effectiveness of high-efficiency ablation of atrial fibrillation complicated with heart failure.

Official title: Clinical Study on the 2C3L Strategy Based on Marshall Venous Chemoablation for the Treatment of Persistent Atrial Fibrillation Combined With Heart Failure

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

130

Start Date

2022-06-16

Completion Date

2025-06-16

Last Updated

2024-06-03

Healthy Volunteers

No

Interventions

PROCEDURE

VOM ethanol chemical ablation and 2C3L

Annular pulmonary vein ablation, mitral isthmus line ablation, tricuspid isthmus line ablation, apex line ablation,anhydrous alcohol ablation of VOM

PROCEDURE

2C3L

Annular pulmonary vein ablation, mitral isthmus line ablation, tricuspid isthmus line ablation, apex line ablation

Locations (1)

Hesheng Hu

Jinan, Shandong, China